A genetic risk score predicts de novo hepatocellular carcinoma in hepatits c cirrhotic patients treated with direct-acting antivirals. (February 2020) - Degasperi, E.; Galmozzi, E.; Pelusi, S.; D'Ambrosio, R.; Soffredini, R.; Borghi, M.; Perbellini, R.; Facchetti, F.; Iavarone, M.; Sangiovanni, A.; Valenti, L.; Lampertico, P.